The use of radioisotope combined with isosulfan blue dye is not superior to radioisotope alone for the identification of sentinel lymph nodes in patients with breast cancer

Surgery

Volumn 144, Issue 4, 2008, Pages 606-610

  Bines, Steven ^a   Kopkash, Katherine ^a   Ali, Amjad ^a   Fogg, Louis ^b   Wool, Norman ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY COLLEGE OF NURSING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ISOSULFAN BLUE; TECHNETIUM SULFUR COLLOID TC 99M;

ARTICLE; BREAST CANCER; CANCER INVASION; HUMAN; INJECTION SITE; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE; TUMOR LOCALIZATION;

ADULT; AGED; ANALYSIS OF VARIANCE; BREAST NEOPLASMS; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; COLORING AGENTS; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; LINEAR MODELS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RADIOISOTOPES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; ROSANILINE DYES; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 51449108848     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2008.06.023     Document Type: Article

References (25)

1. Silverstein M.J., Skinner K.A., and Lomis T.J. Predicting axillary nodal positivity in 2282 patients with breast carcinoma. World J Surg 25 (2001) 767-772
2. Krag D.N., Weaver D.L., Alex J.C., and Fairbank J.T. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2 (1993) 335-339
3. Veronesi U., Paganelli G., Viale G., Luini A., Zurrida S., Galimberti V., et al. A randomized comparison of sentinel node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349 (2003) 546-553
4. Krag D.N., Julian T.B., Harlow S.P., Weaver D.L., Ashikaga T., Bryant J., et al. NSABP-32: phase III, randomized trial comparing axillary resection with sentinel lymph node resection: a description of the trial. Ann Surg Oncol 11 3 Suppl (2004) 208S-210S
5. American Cancer Society National Comprehensive Cancer Network Guidelines. www.nccn.org/professionals/physician_gls/default.asp.
6. Lyman G.H., Giuliano A.E., Somerfield M.R., Benson III A.B., Bodurka D.C., Burstein H.J., et al. American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer. J Clin Oncol 23 (2005) 7703-7720
7. Scherer K., Studer W., Figueiredo V., and Bircher A.J. Anaphylaxis to isosulfan blue and cross-reactivity to patent blue V: case report and review of the nomenclature of vital blue dyes. Ann Allergy Asthma Immunol 96 (2006) 497-500
8. Amr D., Broderick-Villa G., Haigh P.I., Guenther J.M., and Difronzo L.A. Adverse drug reactions during lymphatic mapping and sentinel lymph node biopsy for solid neoplasms. Am Surg 71 (2005) 720-724
9. Raut C.P., Hunt K.K., Akins J.S., Daley M.D., Ross M.I., Singletary S.E., et al. Incidence of anaphylactoid reactions to isosulfan blue dye during breast carcinoma lymphatic mapping in patients treated with preoperative prophylaxis: results of a surgical prospective clinical practice protocol. Cancer 104 (2005) 692-699
10. Heinle E., Burdumy T., and Recabaren J. Factitious oxygen desaturation after isosulfan blue injection. Am Surg 69 (2003) 899-901
11. Pinero A., Illana J., Garcia-Palenciano C., Canizares F., Canteras M., Canadillas V., et al. Effect on oximetry of dyes used for sentinel lymph node biopsy: are there differences?. Arch Surg 139 (2004) 1204-1207
12. Raut C.P., Daley M.D., Hunt K.K., Akins J., Ross M.I., Singletary S.E., et al. Anaphylactoid reactions to isosulfan blue dye during breast cancer lymphatic mapping in patients given preoperative prophylaxis. J Clin Oncol 22 (2004) 567-568
13. King T.A., Fey J.V., Van Zee K.J., Jeert A.S., Gemignani M.L., Port E.R., et al. A prospective analysis of the effect of blue-dye volume on sentinel lymph node mapping success and incidence of allergic reaction in patients with breast cancer. Ann Surg Oncol 11 (2004) 535-541
14. Golshan M., and Nakhlis F. Can methylene blue only be used in sentinel lymph node biopsy for breast cancer?. Breast J 12 (2006) 428-430
15. Stradling B., Aranha G., and Gabram S. Adverse skin lesions after methylene blue injections for sentinel lymph node localization. Am J Surg 184 (2002) 350-352
16. Degnim A.C., Oh K., Cimmino V.M., Diehl K.M., Chang A.E., Newman L.A., et al. Is blue dye indicated for sentinel lymph node biopsy in breast cancer patients with a positive lymphoscintigram?. Ann Surg Oncol 12 (2005) 712-717
17. Derossis A.M., Fey J., Yeung H., Yeh S.D., Heerdt A.S., Petrek J., et al. A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer. J Am Coll Surg 193 (2001) 473-478
18. Kern K.A. Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99m sulfur colloid. J Am Coll Surg 195 (2002) 467-475
19. Lin K.M., Patel T.H., Ray A., Ota M., Jacobs L., Kuvshinoff B., et al. Intradermal radioisotope is superior to peritumoral blue dye or radioisotope in identifying breast cancer sentinel nodes. J Am Coll Surg 199 (2004) 561-566
20. Zavagno G., Rubello D., Franchini Z., Meggiolaro F., Ballarin A., Casara D., et al. Axillary sentinel lymph nodes in breast cancer: a single lymphatic pathway drains the entire mammary gland. Eur J Surg Oncol 31 (2005) 479-484
21. Kargozaran H., Shah M., Li Y., Beckett L., Gandour-Edwards R., Schneider P.D., et al. Concordance of peritumoral technetium 99M colloid and subareolar blue dye injection in breast cancer sentinel lymph node biopsy. J Surg Res 143 (2007) 126-129
22. Hung W.K., Chan C.M., Ying M., Chong S.F., Mak K.L., and Yip A.W. Randomized clinical trial comparing blue dye with combined dye and isotope for sentinel lymph node biopsy in breast cancer. Br J Surg 92 (2005) 1494-1497
23. Morrow M., Rademaker A.W., Bethke K.P., Talamonti M.S., Dawes L.G., Clausen J., et al. Learning sentinel node biopsy: Results of a prospective randomized trial of two techniques. Surgery 126 (1999) 714-722
24. Newman L.A. Lymphatic mapping and sentinel lymph node biopsy in breast cancer patients: A comprehensive review of variations in performance and technique. J Am Coll Surg 199 (2004) 804-816
25. Newman E.A., and Newman L.A. Lymphatic mapping techniques and sentinel lymph node biopsy in breast cancer. Surg Clin N Am 87 (2007) 353-364